Max Salm
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
-
- Lung Cancer Treatments and Mutations
- Renal cell carcinoma treatment
Papers in
-
- Cancer Genomics and Diagnostics 7
-
- Renal cell carcinoma treatment 3
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Charles Swanton (5 shared papers)Andrew Rowan (3 shared papers)Stuart D. Horswell (3 shared papers)Sacheen Kumar (1 shared paper)Nima Abbassi‐Ghadi (1 shared paper)Daniel Hochhauser (1 shared paper)Sharmin Begum (1 shared paper)Nirupa Murugaesu (1 shared paper)
- Journals
- Genome biology (2 papers)Nature Genetics (1 paper)PLoS Biology (1 paper)Nature Cancer (1 paper)Science (1 paper)
- Partner nations
- United KingdomAustraliaGermany
In The Last Decade
Max Salm
13 papers receiving 4.7k citations
Max Salm's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 2.6k
- Pulmonary and Respiratory Medicine 1.8k
- Oncology 1.4k
- Modeling and Simulation 133
- Pathology and Forensic Medicine 477
Countries citing papers authored by Max Salm
This map shows the geographic impact of Max Salm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Salm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Salm more than expected).
Fields of papers citing papers by Max Salm
This network shows the impact of papers produced by Max Salm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Salm. The network helps show where Max Salm may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Salm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tracking the Evolution of Non–Small-Cell Lung Cancer Hit paper breakdown → | 2017 | 1770 |
| 2 | Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing Hit paper breakdown → | 2014 | 1011 |
| 3 | Spatial and temporal diversity in genomic instability processes defines lung cancer evolution Hit paper breakdown → | 2014 | 912 |
| 4 | Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal Hit paper breakdown → | 2018 | 487 |
| 5 | 2015 | 206 | |
| 6 | 2014 | 196 | |
| 7 | 2015 | 95 | |
| 8 | 2019 | 23 | |
| 9 | 2013 | 23 | |
| 10 | 2014 | 12 | |
| 11 | 2024 | 8 | |
| 12 | 2023 | 7 | |
| 13 | 2014 | 4 |
About Max Salm
Max Salm is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Oncology, having authored 13 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Renal cell carcinoma treatment (3 papers), vaccines and immunoinformatics approaches (2 papers), RNA modifications and cancer (2 papers), Immunotherapy and Immune Responses (2 papers), Lung Cancer Treatments and Mutations (2 papers), Renal and related cancers (2 papers) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Cancer Research (2.6k citations), Pulmonary and Respiratory Medicine (1.8k citations), Oncology (1.4k citations), Modeling and Simulation (133 citations) and Pathology and Forensic Medicine (477 citations). Max Salm has collaborated with scholars based in United Kingdom, Australia and Germany. Frequent co-authors include Charles Swanton, Andrew Rowan, Stuart D. Horswell, Sacheen Kumar, Nima Abbassi‐Ghadi, Daniel Hochhauser, Sharmin Begum, Nirupa Murugaesu, Gareth A. Wilson and Thomas B.K. Watkins. Their work appears in journals such as Genome biology, Nature Genetics, PLoS Biology, Nature Cancer and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.